Differential modulation of cytochrome P450 1a1 by arsenite in vivo and in vitro in C57BL/6 mice

被引:14
|
作者
Anwar-Mohamed, Anwar [1 ]
Abdelhamid, Ghada [1 ]
Amara, Issa E. A. [1 ]
El-Kadi, Ayman O. S. [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2E1, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
AhR; Arsenite; Cyp1a1; Cyp1a2; Cyp1b1; HO-1; Free radicals; ARYL-HYDROCARBON RECEPTOR; HEPATOMA HEPA 1C1C7; CATALYTIC-ACTIVITY; PRIMARY CULTURES; GENE-EXPRESSION; DOWN-REGULATION; MESSENGER-RNA; METABOLIZING-ENZYMES; CONGENIC STRAINS; CYP1A1;
D O I
10.1016/j.freeradbiomed.2013.01.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heavy metals, typified by arsenite (As(III)), have been implicated in altering the carcinogenicity of aryl hydrocarbon receptor (AhR) ligands, typified by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), by modulating the induction of the Cyp1a1 enzyme, but the mechanism remains unresolved. In this study, the effects of As(III) on Cyp1a1 expression and activity were investigated in C57BL/6 mouse livers and isolated hepatocytes. For this purpose, C57BL/6 mice were injected intraperitoneally with As(III) (12.5 mg/kg) in the absence and presence of TCDD (15 mu g/kg) for 6 and 24 h. Furthermore, isolated hepatocytes from C57BL/6 mice were treated with As(III) (1, 5, and 10 mu M) in the absence and presence of TCDD (1 nM) for 3, 6, 12, and 24 h. At the in vivo level, As(III) decreased the TCDD-mediated induction of Cyp1a1 mRNA at 6 h while potentiating its mRNA, protein, and catalytic activity levels at 24 h. At the in vitro level, As(III) decreased the TCDD-mediated induction of Cyp1a1 mRNA in a concentration- and time-dependent manner. Moreover, As(III) decreased the TCDD-mediated induction of Cyp1a1 protein and catalytic activity levels at 24 h. Interestingly, As(III) increased the serum hemoglobin (Hb) levels in animals treated for 24 h. Upon treatment of isolated hepatocytes with Hb alone, there was an increase in the nuclear accumulation of AhR and AhR-dependent luciferase activity. Furthermore, Hb potentiated the TCDD-induced AhR-dependent luciferase activity. Importantly, when isolated hepatocytes were treated for 5 h with As(III) in the presence of TCDD and the medium was then replaced with new medium containing Hb, there was potentiation of the TCDD-mediated effect. Taken together, these results demonstrate for the first time that there is a differential modulation of the TCDD-mediated induction of Cyp1a1 by As(III) in C57BL/6 mouse livers and isolated hepatocytes. Thus, this study implicates Hb as an in vivo-specific modulator. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:52 / 63
页数:12
相关论文
共 50 条
  • [21] Differential expression of neurotrophins in postnatal C57BL/6 mice striatum
    Zermeno, V.
    Espindola, S.
    Mendoza, E.
    Hernandez-Echeagaray, E.
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2009, 5 (02): : 118 - 127
  • [22] Pharmacokinetics and Differential Regulation of Cytochrome P450 Enzymes in Type 1 Allergic Mice
    Tanino, Tadatoshi
    Komada, Akira
    Ueda, Koji
    Bando, Toru
    Nojiri, Yukie
    Ueda, Yukari
    Sakurai, Eiichi
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (12) : 1950 - 1957
  • [23] Inducibility of cytochrome P450 1A1 and chemical carcinogenesis by benzo[a]pyrene in AhR repressor-deficient mice
    Hosoya, Tomonori
    Harada, Nobuhiko
    Mimura, Junsei
    Motohashi, Hozumi
    Takahashi, Satoru
    Nakajima, Osamu
    Morita, Masanobu
    Kawauchi, Shimako
    Yamamoto, Masayuki
    Fujii-Kuriyama, Yoshiaki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 365 (03) : 562 - 567
  • [24] Methylated pentavalent arsenic metabolites are bifunctional inducers, as they induce cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase through AhR- and Nrf2-dependent mechanisms
    Anwar-Mohamed, Anwar
    Elshenawy, Osama H.
    Soshilov, Anatoly A.
    Denison, Michael S.
    Le, X. Chris
    Klotz, Lars-Oliver
    El-Kadi, Ayman O. S.
    FREE RADICAL BIOLOGY AND MEDICINE, 2014, 67 : 171 - 187
  • [25] Human Cytochrome P450 1A1 Is a Novel Target Gene of Liver X Receptor α
    Shibahara, Norihito
    Masunaga, Yuiko
    Iwano, Shunsuke
    Yamazaki, Hiroshi
    Kiyotani, Kazuma
    Kamataki, Tetsuya
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (05) : 451 - 457
  • [26] Regulatory mechanisms modulating the expression of cytochrome P450 1A1 gene by heavy metals
    Korashy, HM
    El-Kadi, AOS
    TOXICOLOGICAL SCIENCES, 2005, 88 (01) : 39 - 51
  • [27] Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes
    Kwon, Yeo-Jung
    Shin, Sangyun
    Chun, Young-Jin
    ARCHIVES OF PHARMACAL RESEARCH, 2021, 44 (01) : 63 - 83
  • [28] Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition
    Walter M. A. Westerink
    Joe C. R. Stevenson
    Willem G. E. J. Schoonen
    Archives of Toxicology, 2008, 82 : 909 - 921
  • [29] Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients
    Shah, Parag P.
    Saurabh, Kumar
    Pant, Mohan C.
    Mathur, Neeraj
    Parmara, Devendra
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 670 (1-2) : 74 - 78
  • [30] Repression of cytochrome P450 1A1 gene expression by oxidative stress: mechanisms and biological implications
    Barouki, R
    Morel, Y
    BIOCHEMICAL PHARMACOLOGY, 2001, 61 (05) : 511 - 516